WELLS FARGO & COMPANY/MN - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 2 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$1,911
+16.8%
2,359
+0.9%
0.00%
Q1 2023$1,636
-5.4%
2,337
-4.7%
0.00%
Q4 2022$1,730
-56.8%
2,451
-8.8%
0.00%
Q3 2022$4,000
+100.0%
2,688
+1.9%
0.00%
Q2 2022$2,000
-85.7%
2,639
-73.2%
0.00%
Q1 2022$14,000
-95.9%
9,850
-85.1%
0.00%
Q4 2021$345,000
+210.8%
66,083
+248.4%
0.00%
Q3 2021$111,000
+1.8%
18,970
+39.8%
0.00%
Q2 2021$109,000
-43.2%
13,569
-41.3%
0.00%
Q1 2021$192,000
-75.8%
23,116
-77.9%
0.00%
Q4 2020$793,000
-15.6%
104,617
+18.6%
0.00%
Q3 2020$940,000
+39.9%
88,191
+98.7%
0.00%
Q2 2020$672,000
+320.0%
44,386
+131.6%
0.00%
Q1 2020$160,000
-61.1%
19,166
-21.2%
0.00%
Q4 2019$411,000
-50.8%
24,307
-46.0%
0.00%
Q3 2019$836,000
-32.6%
45,011
-17.0%
0.00%
Q2 2019$1,241,000
-12.3%
54,204
-19.4%
0.00%
Q1 2019$1,415,000
+181.9%
67,288
+54.0%
0.00%
Q4 2018$502,000
-79.5%
43,680
-59.1%
0.00%
-100.0%
Q3 2018$2,450,000
-35.1%
106,792
-37.0%
0.00%0.0%
Q2 2018$3,777,000
-37.1%
169,410
-35.5%
0.00%
-50.0%
Q1 2018$6,004,000
+271.8%
262,745
+326.3%
0.00%
Q4 2017$1,615,000
+7.5%
61,632
-7.9%
0.00%
Q3 2017$1,502,000
-25.1%
66,896
-8.8%
0.00%
-100.0%
Q2 2017$2,005,000
+37.0%
73,328
+21.2%
0.00%
Q1 2017$1,464,000
+71.6%
60,488
+47.2%
0.00%
Q4 2016$853,000
+10.1%
41,100
+44.4%
0.00%
Q3 2016$775,000
+88.1%
28,460
-0.7%
0.00%
Q2 2016$412,000
-8.6%
28,650
-8.8%
0.00%
Q1 2016$451,000
-34.0%
31,423
-1.1%
0.00%
Q4 2015$683,000
+243.2%
31,779
+158.2%
0.00%
Q3 2015$199,000
+5.9%
12,308
+69.0%
0.00%
Q2 2015$188,000
+91.8%
7,281
+67.3%
0.00%
Q1 2015$98,000
+308.3%
4,352
+248.7%
0.00%
Q4 2014$24,000
-7.7%
1,248
+0.7%
0.00%
Q3 2014$26,000
-38.1%
1,239
-23.3%
0.00%
Q2 2014$42,000
+281.8%
1,615
+223.0%
0.00%
Q1 2014$11,000
-87.1%
500
-92.9%
0.00%
Q4 2013$85,000
-14.1%
7,000
-4.8%
0.00%
Q3 2013$99,0007,3530.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders